Human Papillomavirus News and Research RSS Feed - Human Papillomavirus News and Research

Cancer-fighting cocktail shows promising results for advanced cervical cancer

Cancer-fighting cocktail shows promising results for advanced cervical cancer

Combining a standard chemotherapy drug with a second drug that stops cells from dividing improves both the survival and response rates for those with advanced cervical cancer, a new study by UT Southwestern Medical Center cancer researchers finds. [More]
61% less cases of genital warts among women after introducing HPV vaccination program

61% less cases of genital warts among women after introducing HPV vaccination program

GPs in Australia are managing 61 per cent less cases of genital warts among young women since the introduction of the national human papillomavirus (HPV) vaccination program, a new study from the University of Sydney reveals. [More]
Viewpoints: Employers and health benefits; Sen. Pryor's ACA endorsement; waging war on hep C

Viewpoints: Employers and health benefits; Sen. Pryor's ACA endorsement; waging war on hep C

Most of the political class seems to have decided that ObamaCare is working well enough, the opposition is fading, and the subsidies and regulation are settling in as the latest wing of the entitlement state. [More]
Trovagene announces results from clinical studies on urine-based diagnostic test for detection of HPV

Trovagene announces results from clinical studies on urine-based diagnostic test for detection of HPV

Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that results from two clinical studies will be presented at the 29th International Papillomavirus conference for the Company's urine-based diagnostic test for the detection of high risk strains of Human Papillomavirus. [More]
Research roundup: The effect of expensive cancer therapies; missed hospital handovers; children's mental health needs

Research roundup: The effect of expensive cancer therapies; missed hospital handovers; children's mental health needs

Medicare uses more than a dozen different payment systems to set payment rates for the medical items and services the program covers for beneficiaries. [More]
Blood test can predict recurrence of HPV-linked oral cancers

Blood test can predict recurrence of HPV-linked oral cancers

Research published yesterday indicates that recurrence of human papillomavirus (HPV)-induced cancers affecting the oropharynx (the area of the throat just behind the mouth) can be predicted by blood and saliva tests that screen for DNA fragments from HPV that have been shed by cancer cells. [More]
Blood and saliva tests help accurately predict recurrences of HPV associated oral cancers

Blood and saliva tests help accurately predict recurrences of HPV associated oral cancers

Physicians at Johns Hopkins have developed blood and saliva tests that help accurately predict recurrences of HPV-linked oral cancers in a substantial number of patients. [More]
Genticel provides update on patents granted in the USA and Asia

Genticel provides update on patents granted in the USA and Asia

Genticel, a French biotechnology company and leading developer of therapeutic vaccines, provides an update on patents that have recently enriched its intellectual property estate. [More]
Uptake of HPV vaccine in US is unacceptably low

Uptake of HPV vaccine in US is unacceptably low

Data from the CDC's 2013 National Immunization Survey-Teen (NIS-Teen) published today show that the human papillomavirus (HPV) vaccine continues to be underutilized. [More]
HPV vaccination may be effective in reducing abnormal Pap test results even after sexual debut

HPV vaccination may be effective in reducing abnormal Pap test results even after sexual debut

Minority women who received the Human Papillomavirus Vaccination (HPV) even after becoming sexually active had lower rates of abnormal Pap test results than those who were never vaccinated. [More]
Advaxis, MedImmune team up for immuno-oncology clinical trial

Advaxis, MedImmune team up for immuno-oncology clinical trial

Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration with MedImmune, the global biologics research and development arm of AstraZeneca. [More]
Study does not find association between HPV vaccination and increased risk of blood clot

Study does not find association between HPV vaccination and increased risk of blood clot

Although some data has suggested a potential association between receipt of the quadrivalent human papillomavirus (HPV) vaccination and subsequent venous thromboembolism (VTE; blood clot), an analysis that included more than 500,000 women who received the vaccine did not find an increased risk of VTE, according to a study in the July 9 issue of JAMA. [More]

Survey shows biggest barrier to receiving Human Papillomavirus vaccine

A survey of first-year Grand Valley State University students showed the biggest barrier to receiving a Human Papillomavirus (HPV) vaccine was moral or religious beliefs, or a perceived promotion of sexual behavior, according to graduate physician assistant researchers. [More]
Adeno-associated virus type 2 kills triple-negative breast cancer cells in mice

Adeno-associated virus type 2 kills triple-negative breast cancer cells in mice

A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer may lead to new treatments for breast cancer. [More]
Inovio evaluates responses of immunotherapy product in treating HPV linked head and neck cancer

Inovio evaluates responses of immunotherapy product in treating HPV linked head and neck cancer

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity and clinical responses of its immunotherapy product, INO-3112, in treating human papillomavirus (HPV)- associated head and neck cancer. [More]
New vaccine effective at preventing lung cancer in mice

New vaccine effective at preventing lung cancer in mice

Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice. [More]
69% of healthy American adults are infected with 109 strains of human papillomavirus

69% of healthy American adults are infected with 109 strains of human papillomavirus

In what is believed to be the largest and most detailed genetic analysis of its kind, researchers at NYU Langone Medical Center and elsewhere have concluded that 69 percent of healthy American adults are infected with one or more of 109 strains of human papillomavirus (HPV). [More]
Cervical cancer rates in US higher than previously believed, particularly among older women

Cervical cancer rates in US higher than previously believed, particularly among older women

Cervical cancer rates in the United States are higher than previously believed, particularly among 65- to 69-year-old women and African-American women, according to a study led by a researcher at the University of Maryland School of Medicine published in the journal Cancer. [More]
Luminescent nanocrystals tags with high-speed scanning technology detects multiple viruses within minutes

Luminescent nanocrystals tags with high-speed scanning technology detects multiple viruses within minutes

A research team using tunable luminescent nanocrystals as tags to advance medical and security imaging have successfully applied them to high-speed scanning technology and detected multiple viruses within minutes. [More]
No increased HPV-linked oral cancer risk for long-term partners, says study

No increased HPV-linked oral cancer risk for long-term partners, says study

Partners of patients diagnosed with human papilloma virus (HPV)-positive oropharyngeal cancer (OPC) were no more likely to test positive for oral HPV infection than people in the general population, according to a study published in the April 28 online edition of the Journal of Clinical Oncology. [More]